Literature DB >> 24306222

Differential expression of proteins in brain regions of Alzheimer's disease patients.

Saadia Zahid1, Michael Oellerich, Abdul R Asif, Nikhat Ahmed.   

Abstract

Alzheimer's disease (AD), a progressive neurodegenerative disorder and the most common form of dementia and cognitive impairment is usually characterized by neuritic amyloid plaques, cerebrovascular amyloidosis and neurofibrillary tangles. In order to find out the pathological protein expression, a quantitative proteome analysis of AD hippocampus, substantia nigra and cortex was performed and the extent of protein expression variation not only in contrast to age-matched controls but also among the understudied regions was analyzed. Expression alterations of 48 proteins were observed in each region along with significant co/contra regulation of malate dehydrogenase, lactate dehydrogenase B chain, aconitate hydratase, protein NipSnap homolog 2, actin cytoplasmic 1, creatine kinase U-type and glyceraldehyde-3-phosphate dehydrogenase. These differentially expressed proteins are mainly involved in energy metabolism, cytoskeleton integration, apoptosis and several other potent cellular/molecular processes. Interaction association network analysis further confirms the close interacting relationship between the co/contra regulated differentially expressed proteins among all the three regions. Elucidation of co/contra regulation of differentially expressed proteins will be helpful to understand disease progression and functional alterations associated with AD.

Entities:  

Mesh:

Year:  2013        PMID: 24306222     DOI: 10.1007/s11064-013-1210-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.

Authors:  John F Reilly; Dora Games; Russell E Rydel; Stephen Freedman; Dale Schenk; Warren G Young; John H Morrison; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-15       Impact factor: 11.205

2.  Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts.

Authors:  J L Mazzola; M A Sirover
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

3.  A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.

Authors:  C A Davies; D M Mann; P Q Sumpter; P O Yates
Journal:  J Neurol Sci       Date:  1987-04       Impact factor: 3.181

4.  Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia.

Authors:  J O Rinne; J Rummukainen; L Paljärvi; E Säkö; P Mölsä; U K Rinne
Journal:  Prog Clin Biol Res       Date:  1989

Review 5.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

6.  Proteomic identification of nitrated proteins in Alzheimer's disease brain.

Authors:  Alessandra Castegna; Visith Thongboonkerd; Jon B Klein; Bert Lynn; William R Markesbery; D Allan Butterfield
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

7.  Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.

Authors:  Emmanuel Planel; Tomohiro Miyasaka; Thomas Launey; De-Hua Chui; Kentaro Tanemura; Shinji Sato; Ohoshi Murayama; Koichi Ishiguro; Yoshitaka Tatebayashi; Akihiko Takashima
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

8.  14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin.

Authors:  Antje Gohla; Gary M Bokoch
Journal:  Curr Biol       Date:  2002-10-01       Impact factor: 10.834

9.  STRING 8--a global view on proteins and their functional interactions in 630 organisms.

Authors:  Lars J Jensen; Michael Kuhn; Manuel Stark; Samuel Chaffron; Chris Creevey; Jean Muller; Tobias Doerks; Philippe Julien; Alexander Roth; Milan Simonovic; Peer Bork; Christian von Mering
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

10.  The creatine kinase/creatine connection to Alzheimer's disease: CK-inactivation, APP-CK complexes and focal creatine deposits.

Authors:  Tanja S Bürklen; Uwe Schlattner; Ramin Homayouni; Kathleen Gough; Margaret Rak; Adriana Szeghalmi; Theo Wallimann
Journal:  J Biomed Biotechnol       Date:  2006
View more
  13 in total

1.  Mitochondrial Proteome Changes Correlating with β-Amyloid Accumulation.

Authors:  Katalin Völgyi; Krisztina Háden; Viktor Kis; Péter Gulyássy; Kata Badics; Balázs András Györffy; Attila Simor; Zoltán Szabó; Tamás Janáky; László Drahos; Árpád Dobolyi; Botond Penke; Gábor Juhász; Katalin Adrienna Kékesi
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

2.  Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology.

Authors:  Sonia Do Carmo; Gogce Crynen; Tiffany Paradis; Jon Reed; M Florencia Iulita; Adriana Ducatenzeiler; Fiona Crawford; A Claudio Cuello
Journal:  Mol Neurobiol       Date:  2017-05-13       Impact factor: 5.590

3.  Chronic Exposure to β-Alanine Generates Oxidative Stress and Alters Energy Metabolism in Cerebral Cortex and Cerebellum of Wistar Rats.

Authors:  Tanise Gemelli; Rodrigo Binkowski de Andrade; Denise Bertin Rojas; Ângela Zanatta; Gabriel Henrique Schirmbeck; Cláudia Funchal; Moacir Wajner; Carlos Severo Dutra-Filho; Clovis Milton Duval Wannmacher
Journal:  Mol Neurobiol       Date:  2017-08-24       Impact factor: 5.590

Review 4.  The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.

Authors:  Kaitlyn E Stepler; Renã A S Robinson
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

5.  Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.

Authors:  Eleanor Drummond; Shruti Nayak; Arline Faustin; Geoffrey Pires; Richard A Hickman; Manor Askenazi; Mark Cohen; Tracy Haldiman; Chae Kim; Xiaoxia Han; Yongzhao Shao; Jiri G Safar; Beatrix Ueberheide; Thomas Wisniewski
Journal:  Acta Neuropathol       Date:  2017-03-04       Impact factor: 15.887

6.  Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.

Authors:  María Victoria Zelaya; Estela Pérez-Valderrama; Xabier Martínez de Morentin; Teresa Tuñon; Isidro Ferrer; María Rosario Luquin; Joaquín Fernandez-Irigoyen; Enrique Santamaría
Journal:  Oncotarget       Date:  2015-11-24

7.  Dementia-linked amyloidosis is associated with brain protein deamidation as revealed by proteomic profiling of human brain tissues.

Authors:  Sunil S Adav; Xavier Gallart-Palau; Kok Hian Tan; Sai Kiang Lim; James P Tam; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-02-19       Impact factor: 4.041

8.  Alzheimer's disease: are blood and brain markers related? A systematic review.

Authors:  Ali T Khan; Richard J B Dobson; Martina Sattlecker; Steven J Kiddle
Journal:  Ann Clin Transl Neurol       Date:  2016-05-11       Impact factor: 4.511

9.  Glaucoma related Proteomic Alterations in Human Retina Samples.

Authors:  Sebastian Funke; Natarajan Perumal; Sabine Beck; Silke Gabel-Scheurich; Carsten Schmelter; Julia Teister; Claudia Gerbig; Oliver W Gramlich; Norbert Pfeiffer; Franz H Grus
Journal:  Sci Rep       Date:  2016-07-18       Impact factor: 4.379

10.  Neonatal Neurodegeneration in Alzheimer's Disease Transgenic Mouse Model.

Authors:  Aise Rumeysa Mazi; Aysegul Sumeyye Arzuman; Busra Gurel; Betul Sahin; Mete Bora Tuzuner; Mehmet Ozansoy; Ahmet Tarik Baykal
Journal:  J Alzheimers Dis Rep       Date:  2018-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.